Testing effectiveness (Phase 2)Ended earlyNCT03298022
What this trial is testing
Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC
Who this might be right for
Ulcerative Colitis
AltruBio Inc. 24